MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0018044
Tervis Therapeutics LLP
Tervis Therapeutics LLP - research & development in Hyderabad, Telangana, India. Directors, charges & compliance details.
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
5 yrs
Est. 2021
Employees · EPFO
53
Provident fund records
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2024
Balance sheet date
LLP status
Active
MCA master data
Registrar
Hyderabad
ROC office
About Tervis Therapeutics LLP
Data last updated:
Tervis Therapeutics LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the research and development sector. It was incorporated on 03 June 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAX-2612. Its GSTIN is 36AARFT7068G1ZJ (Telangana).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sandhya Rani Bandla and Manikanth Reddy Yarala.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Shed No – 3B Type – 1 Sy No. 386 Industrial Estate Tsiic Prashanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
The LLP has about 53 employees on its provident fund (EPFO) records.
Tervis Therapeutics LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0018044).
Company details
LLPIN AAX-2612
Incorporation Date 03 June 2021
Total Obligation of Contribution ₹1 Lakh
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-TS-20-0018044
Recognitions & Rankings of Tervis Therapeutics
Contact details
Tervis Therapeutics LLP's registered office is in Hyderabad, Telangana.
- Registered AddressShed No – 3B Type – 1 Sy No. 386 Industrial Estate Tsiic Prashanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryResearch & Development, Research & Development
Comprehensive company report
Tervis Therapeutics LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Tervis Therapeutics LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Tervis Therapeutics LLP, buy the company report.
Designated partners of Tervis Therapeutics LLP
Tervis Therapeutics has 2 designated partners on record. No former designated partners are listed.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Rani Bandla | Designated Partner | 03 Jun 2021 | 5 Years 4 Months | Current |
| Manikanth Reddy Yarala | Designated Partner | 03 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Tervis Therapeutics LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tervis Therapeutics LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tervis Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AARFT7068G1ZJ | Telangana | Active | 11 Jul 2021 |
To see the full GST registrations and return filing status of Tervis Therapeutics LLP, buy the company report.
Recent activity
Tervis Therapeutics LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Manikanth Reddy Yarala was appointed as Designated Partner on 03 Jun 2021.
AGM
Tervis Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Tervis Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Manikanth Reddy Yarala was appointed as Designated Partner.
Appointed
Sandhya Rani Bandla was appointed as Designated Partner.
Incorporation
03 Jun 2021
Tervis Therapeutics Llp was registered on 03 Jun 2021 with Roc Hyderabad & aged 5 years 4 months as per MCA records.
Frequently asked questions
Tervis Therapeutics is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in the research and development industry. It was incorporated on 03 June 2021 (5+ years old) and is registered under LLPIN AAX-2612.
Tervis Therapeutics has 2 current designated partners:
- Sandhya Rani Bandla - Designated Partner
- Manikanth Reddy Yarala - Designated Partner
The latest financial statements of Tervis Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Tervis Therapeutics is 36AARFT7068G1ZJ, registered in Telangana.
The LLPIN (Limited Liability Partnership Identification Number) of Tervis Therapeutics is AAX-2612. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Tervis Therapeutics was incorporated on 03 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Manikanth Reddy Yarala was appointed as Designated Partner on 03 Jun 2021. Sandhya Rani Bandla was appointed as Designated Partner on 03 Jun 2021.
Yes, Tervis Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0018044).
The registered office of Tervis Therapeutics is at Shed No – 3B Type – 1 Sy No. 386 Industrial Estate Tsiic Prashanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Tervis Therapeutics operates in the research and development industry.